LI AUTO INC - ADR (LI)
US50202M1027 - ADR
LI AUTO INC - ADR
NASDAQ:LI (12/23/2024, 8:16:41 PM)
After market: 24.17 +0.06 (+0.25%)24.11
+0.55 (+2.33%)
Company Profile
Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. The company is headquartered in Beijing, Beijing and currently employs 31,591 full-time employees. The company went IPO on 2020-07-30. The main products include Li MEGA, high-voltage battery electric vehicle; Li L9, a six-seat flagship family sport utility vehicle (SUV); Li L8, a six-seat family SUV; Li L7, a five-seat flagship family SUV. The firm is also engaged in the provision of value-added services such as paid regular servicing of the vehicle, free vehicle pick-ups and deliveries, unlimited high-speed data plan, discounts on service and products offerings, installation of charging stalls, and vehicle internet connection services.
Company Info
LI AUTO INC - ADR
11 Wenliang Street, Shunyi District
Beijing BEIJING 101399
P: 861087427209
CEO: Xiang Li
Employees: 30899
Website: https://www.lixiang.com/
LI News
7 days ago - ChartmillInvestors seeking growth at a reasonable cost should explore NASDAQ:LI.Investors seeking growth at a reasonable cost should explore NASDAQ:LI.
15 days ago - ChartmillNASDAQ:LI, a strong growth stock, setting up for a breakout.Is LI AUTO INC - ADR (NASDAQ:LI) on the Verge of a Major Breakout as a Strong Growth Stock?
23 days ago - Li Auto Inc.Li Auto Inc. November 2024 Delivery Update23 days ago - Li Auto Inc.Li Auto Inc. November 2024 Delivery UpdateBEIJING, China, Dec. 01, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy...
24 days ago - Investor's Business DailyNo. 1 Tesla Rival BYD Prepares For Sharper Price War; EV Sales DueChina EV makers have been launching new models and offering discounts.
26 days ago - Lanchi VenturesLanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline/PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC)...
LI Twits
Here you can normally see the latest stock twits on LI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
